COVID Clinical Trial
Official title:
Intensive Care Therapy of Covid-19 Disease in Germany an Multi-center Observational Study
| NCT number | NCT04455451 |
| Other study ID # | DCIR |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | August 6, 2020 |
| Est. completion date | September 30, 2021 |
| Verified date | September 2021 |
| Source | University Hospital Tuebingen |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Multi-center retrospective and prospective observational study of Covid-19 patients with severe or critical illness treated on a German ICU
| Status | Completed |
| Enrollment | 2054 |
| Est. completion date | September 30, 2021 |
| Est. primary completion date | August 15, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Age above 18 years - Covid-19 disease (positive SARS-CoV-2 PCR) Exclusion Criteria: -none |
| Country | Name | City | State |
|---|---|---|---|
| Germany | RWTH Aachen - Department for operative Intensive Care Medicine and intermediate Care | Aachen | |
| Germany | Zollernalbklinikum | Balingen | |
| Germany | Charité Universitätsmedizin Berlin | Berlin | |
| Germany | UH Bochum - Department for Anesthesiology and Intensive Care Medicine | Bochum | |
| Germany | Universitätsklinikum Bonn | Bonn | |
| Germany | Universitätsklinikum Carl Gustav Carus Dresden | Dresden | |
| Germany | Ev. Krankenhaus Bethesda Duisburg Klinik für Anästhesiologie und Intensivmedizin | Duisburg | |
| Germany | Univerrsitätsklinikum Düsseldorf | Düsseldorf | |
| Germany | Universitätsklinikum Essen | Essen | |
| Germany | Universitätsklinikum Frankfurt | Frankfurt | |
| Germany | University Hospital Freiburg - Department for Anesthesiology and Intensive Care Medicine | Freiburg | |
| Germany | Universitätsklinikum Giessen Klinik für Anaesthesiologie und operative Intensivmedizin | Gießen | |
| Germany | Universitätsmedizin Göttingen Klinik für Anästhesiologie | Göttingen | |
| Germany | Universitätsklinikum Greifswald | Greifswald | |
| Germany | Universitätsklinikum Halle | Halle/Saale | |
| Germany | University Hospital Heidelberg - Department for Anesthesiologie and Intensive Care Medicine | Heidelberg | |
| Germany | Universitätsklinikum des Saarlandes | Homburg/Saar | |
| Germany | Klinikum der Universität Witten/Herdecke - Köln / Klinik für Anästhesiologie und operative Intensivmedizin | Köln | |
| Germany | Universitätsklinikum Leipzig | Leipzig | |
| Germany | UKSH Campus Lübeck - Department for Anesthesiology and Intensive Care Medicine | Lübeck | |
| Germany | University Hospital Magdeburg - Department for Anesthesiology and Intensive Care Medicine | Magdeburg | |
| Germany | Universitätsklinikum Marburg | Marburg | |
| Germany | Technische Universität München | München | |
| Germany | Oberschwabenklinik Ravensburg Klinik für Anästhesie-, Intensiv-, Notfall- und Schmerzmedizin | Ravensburg | |
| Germany | University Hospital Tübingen - Department for Anesthesiology and Intensive Care Medicine | Tübingen | |
| Germany | Universitätsklinikum Ulm | Ulm | |
| Germany | Universitätsklinikum Würzburg Klinik und Poliklinik für Anästhesiologie, Intensivmedizin und Schmerztherapie | Würzburg |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital Tuebingen |
Germany,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Mortality | ICU Mortality of patients | up to 150 days | |
| Secondary | ICU length of stay | Intensive care unit length of stay | up to 150 days |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04558125 -
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
|
Phase 4 | |
| Recruiting |
NCT04410510 -
P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT04420676 -
Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection
|
N/A | |
| Completed |
NCT04419025 -
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
|
Phase 2 | |
| Completed |
NCT04425317 -
Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients
|
N/A | |
| Completed |
NCT04395911 -
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
|
N/A | |
| Withdrawn |
NCT04456426 -
Characteristics of Patients With COVID-19 in Meta State, Colombia
|
||
| Completed |
NCT04526769 -
Detecting SARS-CoV-2 in Tears
|
||
| Completed |
NCT04425720 -
Use of Remote Monitoring for COVID-19 Patient
|
N/A | |
| Suspended |
NCT04385771 -
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
|
N/A | |
| Completed |
NCT04419610 -
RAS and Coagulopathy in COVID19
|
Early Phase 1 | |
| Completed |
NCT04546581 -
Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
|
Phase 3 | |
| Completed |
NCT04435327 -
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
|
||
| Terminated |
NCT04530448 -
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
|
Phase 4 | |
| Not yet recruiting |
NCT04524156 -
COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2
|
N/A | |
| Completed |
NCT04441710 -
Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus
|
||
| Completed |
NCT04357834 -
WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
|
||
| Not yet recruiting |
NCT04392427 -
New Antiviral Drugs for Treatment of COVID-19
|
Phase 3 | |
| Terminated |
NCT04614025 -
Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19
|
Phase 2 | |
| Completed |
NCT04402957 -
LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
|
Phase 2 |